1st Northwest Hospital Begins Certification Program to Implant the World's Only Approved Total Artificial Heart
Sacred Heart Medical Center to Become 14th U.S. SynCardia Certified Center
TUCSON, Ariz. – Oct. 7, 2010 – On Oct. 4 & 5, the surgical team from Sacred Heart Medical Center, one of the largest hospitals in the Northwest, led by Timothy B. Icenogle, M.D., Director of the Mechanical Heart Program, completed the first phase of certification to implant the SynCardia temporary Total Artificial Heart. Sacred Heart is scheduled to complete Phase II of certification on Oct. 12 & 13, followed by the proctored first implant after an appropriate patient has been identified.
"At Sacred Heart, we receive lots of referrals from local and regional facilities for their most severe and complicated cardiac cases," said Dr. Icenogle. "We are very excited to offer the Total Artificial Heart to patients dying from biventricular heart failure. The Total Artificial Heart serves as a life-saving bridge to transplant for some of the sickest patients."
Dr. Icenogle completed his residency in cardiothoracic surgery at the University of Arizona under the leadership of Dr. Jack Copeland, who has performed more than 100 implants of the Total Artificial Heart. Upon performing its first implant, Sacred Heart will become the 1st SynCardia Certified Center in the Northwest and the 14th in the U.S. Dr. Icenogle previously implanted the Total Artificial Heart when he was an assistant professor at the University of Arizona.
Sacred Heart has had excellent heart transplant survival rates and its permanent mechanical heart assist device survival rates have now reached 90%, among the highest in the nation. Sacred Heart performs three times as many cardiovascular procedures as any other hospital in the region (Department of Health, 2006) and ranks in the nation's top 10% of hospitals in treating patients for heart attack and congestive heart failure, according to Premier, Inc.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463